These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 14220146)
21. HEMORRHAGE DUE TO FIBRINOLYSIS OCCURRING WITH OPEN-HEART OPERATIONS. TICE DA; REED GE; CLAUSS RH; WORTH MH J Thorac Cardiovasc Surg; 1963 Nov; 46():673-9. PubMed ID: 14087740 [No Abstract] [Full Text] [Related]
22. [A NEW METHOD OF THE ANALYSIS OF EPSILON-AMINOCAPROIC ACID (EACA) AND AMINOMETHYLCYCLOHEXANE CARBOXYLIC ACID (AMCHA), THE POTENT ANTIFIBRINOLYTIC AGENTS]. TAKATA Y; TAKATA A; OKAMOTO U Nihon Seirigaku Zasshi; 1964 May; 26():281-5. PubMed ID: 14172890 [No Abstract] [Full Text] [Related]
23. [THERAPY OF POSTOPERATIVE HEMORRHAGE FOLLOWING PROSTATECTOMY WITH SPECIAL REFERENCE TO THE EFFECT OF 6-AMINOCAPROIC ACID]. SCHMUTZLER R Helv Chir Acta; 1963 Nov; 30():518-21. PubMed ID: 14102834 [No Abstract] [Full Text] [Related]
31. EFFECTS OF EPSILON AMINOCAPROIC ACID ON COAGULATION AND FIBRINOLYTIC MECHANISMS. LEWIS JH; DOYLE AP JAMA; 1964 Apr; 188():56-63. PubMed ID: 14107215 [No Abstract] [Full Text] [Related]
32. [OBSTETRICAL HEMORRHAGIC SYNDROMES. OBSERVATIONS AND CONSIDERATIONS OF A PHYSIOPATHOLOGICAL, CLINICAL AND THERAPEUTIC NATURE]. MARZETTI L; MORINI A Minerva Ginecol; 1964 Feb; 16():95-106. PubMed ID: 14137002 [No Abstract] [Full Text] [Related]
33. FIBRINOLYSIS AND FORMATION OF BIOLOGICALLY ACTIVE POLYPEPTIDES. EISEN V Br Med Bull; 1964 Sep; 20():205-9. PubMed ID: 14209760 [No Abstract] [Full Text] [Related]
34. THE INHIBITION OF TRASYLOL OF FIBRINOLYTIC ACTIVITY ASSOCIATED WITH CARDIOVASCULAR OPERATIONS. TICE DA; WORTH MH; CLAUSS RH; REED GH Surg Gynecol Obstet; 1964 Jul; 119():71-4. PubMed ID: 14179354 [No Abstract] [Full Text] [Related]
35. AORTIC ARTERIOSCLEROSIS IN RABBITS. FED INHIBITORS OF FIBRINOLYSIS. KWAAN HC; ASTRUP T Arch Pathol; 1964 Nov; 78():474-82. PubMed ID: 14200668 [No Abstract] [Full Text] [Related]
36. [CLINICAL RESULTS OBTAINED BY THE USE OF ANTIFIBRINOLYTIC AGENT]. LENOIR P; TURPIN J; PAWLOTSKY Y; NOURY S; GOUFFAULT J; BOUREL M Therapie; 1964; 19():1651-6. PubMed ID: 14242733 [No Abstract] [Full Text] [Related]
38. [CURRENT STATUS OF OUR IDEAS ON FIBRINOLYSIS. PREVENTION AND TREATMENT WITH ENZYME INHIBITORS]. LEGER L; VAIREL E Acta Chir Belg; 1963 Sep; 62():655-63. PubMed ID: 14089249 [No Abstract] [Full Text] [Related]
39. [INHIBITORS OF FIBRINOLYSIS IN THE TREATMENT OF HEMORRHAGE, HEMORRHAGIC DIATHESIS AND SOME OTHER PATHOLOGICAL CONDITIONS. I. SPECIFIC INHIBITORS OF FIBRINOLYSIS]. NIEWIAROWSKI S Pol Arch Med Wewn; 1964; 34():211-7. PubMed ID: 14151493 [No Abstract] [Full Text] [Related]
40. AMINOCAPROIC ACID, AN INHIBITOR OF FIBRINOLYSIS. SWEENEY WM Am J Med Sci; 1965 May; 249():576-89. PubMed ID: 14283294 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]